ArticleJournal of family medicine and primary care2025
Effectiveness of antihypertensive therapies and maternal-neonatal outcomes in preeclampsia and eclampsia women: an analytical retrospective study from sudan.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preeclampsia and eclampsia (PE/E) are significant contributors to maternal and perinatal morbidity and mortality globally. While international guidelines suggest various drugs for managing these conditions, their efficacy in the Sudanese population remains underexplored. This study aimed to evaluate maternal and neonatal outcomes in Sudanese women with PE/E and assess the effectiveness of antihypertensive therapies. Methods: This analytical, retrospective study was conducted at Omdurman Maternity Hospital, Sudan, analyzing medical records of 257 women admitted with PE/E in 2020. Data were collected using a checklist, and SPSS version 25 was used for analysis. Maternal and neonatal outcomes were assessed, and the effectiveness of antihypertensive treatments was evaluated. Results: The mean age of the women was 26.9 ± 7.1 years, with nearly 50% being primigravida. Preeclampsia occurred in 77.8% of cases, and eclampsia in 22.2%. The most prescribed antihypertensive medications were amlodipine, nifedipine, and hydralazine, with magnesium sulfate used for seizure prevention. Blood pressure control was most effective with combinations of nifedipine, methyldopa, and hydralazine, with hydralazine being the most effective ( Conclusions: Hydralazine was the most effective antihypertensive medication for controlling blood pressure in the management of PE/E, with combination therapies like Nifedipine-Methyldopa being particularly effective. Although antihypertensive treatments did not significantly influence maternal or neonatal outcomes, they were effective in managing hypertension. Further research is needed to refine treatment strategies, reduce maternal and neonatal mortality, and highlight the importance of extended postpartum care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.